Endoscopy AI startup, backed by Globis Capital Partners, World Innovation Lab (WiL) and Sony Innovation Fund by IGV, plans to further develop technology, promote clinical trials and expand overseas TOKYO, October 4, 2019-- AI Medical Service Inc., one of the world's first real-time endoscopic artificial intelligence (AI) developers, today announced that it has raised approximately $42.9 million USD in Series B funding from Globis Capital Partners, World Innovation Lab (WiL) and Sony Innovation Fund by IGV (Innovation Growth Ventures), as well as additional third-party allocations.